Anthony Lucci

20.9k total citations · 2 hit papers
254 papers, 11.3k citations indexed

About

Anthony Lucci is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Anthony Lucci has authored 254 papers receiving a total of 11.3k indexed citations (citations by other indexed papers that have themselves been cited), including 164 papers in Oncology, 145 papers in Cancer Research and 54 papers in Pathology and Forensic Medicine. Recurrent topics in Anthony Lucci's work include Breast Cancer Treatment Studies (109 papers), Cancer Cells and Metastasis (64 papers) and Breast Lesions and Carcinomas (48 papers). Anthony Lucci is often cited by papers focused on Breast Cancer Treatment Studies (109 papers), Cancer Cells and Metastasis (64 papers) and Breast Lesions and Carcinomas (48 papers). Anthony Lucci collaborates with scholars based in United States, France and United Kingdom. Anthony Lucci's co-authors include Kelly K. Hunt, Balraj Singh, Henry M. Kuerer, Savitri Krishnamurthy, Armando E. Giuliano, Massimo Cristofanilli, Carolyn Hall, Naoto T. Ueno, Wendy A. Woodward and Funda Meric‐Bernstam and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Anthony Lucci

246 papers receiving 11.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis

2014 1.3k citations Anthony Lucci et al. profile →
Surgical Complications Associated With Sentinel Lymph Node Dissection (SLND) Plus Axillary Lymph Node Dissection Compared With SLND Alone in the American College of Surgeons Oncology Group Trial Z0011

2007 660 citations Anthony Lucci, Kelly K. Hunt et al. profile →

Peers

Countries citing papers authored by Anthony Lucci

Since Specialization

Citations

This map shows the geographic impact of Anthony Lucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Lucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Lucci more than expected).

Fields of papers citing papers by Anthony Lucci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Lucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Lucci. The network helps show where Anthony Lucci may publish in the future.

Co-authorship network of co-authors of Anthony Lucci

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Lucci. A scholar is included among the top collaborators of Anthony Lucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Lucci. Anthony Lucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanoma 2025 ·OncoImmunology ·(unknown), Simin Kiany, Marie‐Andrée Forget, Roland L. Bassett, Michael A. Davies, Adi Diab, Jeffrey E. Gershenwald, Isabella C. Glitza, Jeffrey E. Lee, Anthony Lucci, Jennifer L. McQuade, Sapna P. Patel, Merrick I. Ross, Hussein A. Tawbi, Jennifer A. Wargo, Michael K. Wong, Chantale Bernatchez, Patrick Hwu, Cara Haymaker, Rodabe Navroze Amaria	0
2	Abstract PO3-20-06: TRUDI: A phase II study of neoadjuvant TRastuzumab derUxtecan and Durvalumab for stage III HER2-expressing Inflammatory breast cancer 2024 ·Cancer Research ·Paolo Tarantino, (unknown), Antonio Giordano, Faina Nakhlis, Jennifer R. Bellon, Wendy A. Woodward, Azadeh Nasrazadani, Sadia Saleem, Anthony Lucci, Michelle K. DeMeo, Naoto T. Ueno, Sara M. Tolaney, Vicente Valero, Meredith M. Regan, Rachel M. Layman, Filipa Lynce	2
3	243MO Omission of breast surgery after neoadjuvant systemic therapy for invasive cancer: Three-year preplanned primary-endpoint on a phase II multicentre prospective trial 2023 ·Annals of Oncology ·Henry M. Kuerer, Gaiane M. Rauch, Savitri Krishnamurthy, Emilia J. Diego, Wei Yang, Yu Shen, Heather Lin, Anthony Lucci, Timothy A. Moseley, (unknown), Jason Mouabbi, Judy C. Boughey, Simona F. Shaitelman, Richard L. White, Kelly K. Hunt, Melissa P. Mitchell, Mediget Teshome, Helen M. Johnson, Benjamin D. Smith, Vicente Valero	1
4	Melanoma metastatic to the adrenal gland: An update on the role of adrenalectomy in multidisciplinary management 2023 ·Journal of Surgical Oncology ·Elliot A. Asare, Sarah B. Fisher, Yi‐Ju Chiang, Lauren E. Haydu, Sameer H. Patel, Emily Z. Keung, Anthony Lucci, Jennifer A. Wargo, Jeffrey E. Gershenwald, Merrick I. Ross, Jeffrey E. Lee	5
5	Sensitization of Resistant Cells with a BET Bromodomain Inhibitor in a Cell Culture Model of Deep Intrinsic Resistance in Breast Cancer 2023 ·Cancers ·Balraj Singh, (unknown), (unknown), (unknown), (unknown), (unknown), Sridevi Addanki, Anthony Lucci	3
6	Presence of Circulating Tumor Cells Predates Imaging Detection of Relapse in Patients with Stage III Melanoma 2023 ·Cancers ·Anthony Lucci, Sridevi Addanki, Yi‐Ju Chiang, (unknown), (unknown), (unknown), (unknown), Sapna P. Patel, Jennifer A. Wargo, Jeffrey E. Gershenwald, Merrick I. Ross	3
7	Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast Cancers 2022 ·International Journal of Molecular Sciences ·Sridevi Addanki, (unknown), (unknown), Balraj Singh, Anthony Lucci	28
8	Sensitization of Resistant Breast Cancer Cells with a Jumonji Family Histone Demethylase Inhibitor 2022 ·Cancers ·Balraj Singh, (unknown), Anthony Lucci	2
9	Evaluation of Plasma IL-6 in Patients with Melanoma as a Prognostic and Checkpoint Immunotherapy Predictive Biomarker 2021 ·Journal of Investigative Dermatology ·Yuling Wang, Vijaya Ramachandran, Dawen Sui, (unknown), Lauren E. Haydu, Shenying Fang, Jennifer L. McQuade, Sarah B. Fisher, Anthony Lucci, Emily Z. Keung, Jennifer A. Wargo, Jeffrey E. Gershenwald, Merrick I. Ross, Jeffrey E. Lee	16
10	Circulating Tumor Cells and Early Relapse in Node-positive Melanoma 2020 ·Clinical Cancer Research ·Anthony Lucci, Carolyn Hall, Sapna P. Patel, (unknown), Jessica B. Bauldry, Richard E. Royal, Mandar Karhade, (unknown), Jennifer A. Wargo, Isabella C. Glitza, Michael K. Wong, Rodabe N. Amaria, Hussein A. Tawbi, Adi Diab, Michael A. Davies, Jeffrey E. Gershenwald, Jeffrey E. Lee, Patrick Hwu, Merrick I. Ross	52
11	Correlation of circulating or disseminated tumor cells with the Oncotype DX Recurrence Score 2020 ·Breast Cancer Research and Treatment ·Puneet Singh, Sarah Tevis, Carolyn Hall, (unknown), Rosa F. Hwang, Anthony Lucci	3
12	Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer 2020 ·Cancers ·Kumiko Kida, Kenneth R. Hess, Bora Lim, Toshiaki Iwase, (unknown), Vicente Valero, Anthony Lucci, (unknown), Wendy A. Woodward, Savitri Krishnamurthy, Gabriel N. Hortobágyi, Debu Tripathy, Naoto T. Ueno	1
13	Factors Associated with Pathological Node Negativity in Inflammatory Breast Cancer: Are There Patients Who May be Candidates for a De-Escalation of Axillary Surgery? 2020 ·Annals of Surgical Oncology ·Lauren M. Postlewait, Mediget Teshome, Sarah M. DeSnyder, Bora Lim, Henry M. Kuerer, Isabelle Bedrosian, Wendy A. Woodward, Naoto T. Ueno, Anthony Lucci	12
14	Body mass index mediates the prognostic significance of circulating tumor cells in inflammatory breast cancer 2017 ·The American Journal of Surgery ·Oluwadamilola M. Fayanju, Carolyn Hall, Jessica B. Bauldry, Mandar Karhade, (unknown), Henry M. Kuerer, Sarah M. DeSnyder, Carlos H. Bárcenas, Anthony Lucci	7
15	Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer 2016 ·Clinical Cancer Research ·Wolfgang Janni, Brigitte Rack, Leon W.M.M. Terstappen, Jean‐Yves Pierga, Florin‐Andrei Taran, Tanja Fehm, Carolyn Hall, Marco R. de Groot, François‐Clément Bidard, Thomas W. P. Friedl, Peter A. Fasching, Sara Y. Brucker, Klaus Pantel, Anthony Lucci	265
16	Detection of circulating melanoma cells in the blood of melanoma patients 2015 ·Melanoma Research ·Christina L. Roland, Merrick I. Ross, Carolyn Hall, (unknown), (unknown), Amber Anderson, Anthony Lucci	19
17	International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment 2010 ·Annals of Oncology ·Shaheenah Dawood, Sofía D. Merajver, Patrice Viens, Peter Vermeulen, Sandra M. Swain, Thomas A. Buchholz, Luc Dirix, Paul H. Levine, Anthony Lucci, Savitri Krishnamurthy, Fredika M. Robertson, Wendy A. Woodward, Wei Yang, Naoto T. Ueno, Massimo Cristofanilli	331
18	Trastuzumab in Primary Inflammatory Breast Cancer (IBC): High Pathological Response Rates and Improved Outcome 2010 ·The Breast Journal ·Shaheenah Dawood, Yun Yun Gong, Kristine Broglio, Thomas A. Buchholz, Wendy A. Woodward, Anthony Lucci, Vicente Valero, Ana M. González-Angulo, Gabriel N. Hortobágyi, Massimo Cristofanilli	18
19	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Reverses Mesenchymal to Epithelial Phenotype and Inhibits Metastasis in Inflammatory Breast Cancer 2009 ·Clinical Cancer Research ·Dongwei Zhang, Tiffany A. LaFortune, Savitri Krishnamurthy, Francisco J. Esteva, Massimo Cristofanilli, Ping Liu, Anthony Lucci, Balraj Singh, Mien‐Chie Hung, Gabriel N. Hortobágyi, Naoto T. Ueno	98
20	Novel Clinical Trial Designs for Treatment of Ductal Carcinoma In Situ of the Breast with Trastuzumab (Herceptin) 2007 ·The Breast Journal ·Ricardo J. Gonzalez, Aman U. Buzdar, W. Fraser Symmans, Tina Yen, Kristine Broglio, Anthony Lucci, Francisco J. Esteva, Guosheng Yin, Henry M. Kuerer	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact